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Abstract: Modern medicine has moved by leaps and bounds throughout recent years to literally make science
fiction part of our day-to-day reality. Undoubtedly one of the biggest breakthroughs was the discovery of stem
cells, which was followed up in a breathtaking fashion by report after report of their promise, so much so that
an almost miraculous scenario seems to be infolding in front of the world’s eyes. Stem cells are classified mainly
by their source into three basic types: Embryonic, umbilical and adult stem cells. Each differ in their plasticity
and could thus potentially be used for different medical purposes. However, for this to be possible, lab
techniques for collecting, culturing and perhaps even transdifferenciating different stem cells need to be studied
and outlined, ideally while having a good background of the mechanisms underlying the processes of
differentiation and transdifferentaition, with all the various combinations of growth factor cocktails needed for
the cell culture to be viable commercially and the individual and additive effect of each ingredient on the
resultant culture.
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INTRODUCTION When taking in account all available evidence, the
Stem cell research was launched into the limelight unpredictable. The emerging field of stem cell research
recently by James Thomson, a scientist at the University crosses many disciplinary boundaries, including
of Wisconsin in Madison, who successfully removed reproductive biology, embryology, cell biology, molecular
cells from spare embryos at fertility clinics and grew them biology, endocrinology, immunology, foetal medicine,
in the laboratory, establishing the world’s first human transplantation medicine and surgery. 
Embryonic  Stem  cell  (ES  cell)  line.   In the same year,
Dr. Gearhart isolated cells from 2-4-month-old foetuses MATERIALS AND METHODS
(obtained from elective abortions with infromed consent
from donors who had independently decided to terminate Classification of stem cells in terms of their plasticity.
their preganacy). Gearhart’s team established a different Methods of culturing each type of stem cells in the lab:
line of cell cultures, by collecting cells from the gonadal Stem cells are defined as clonogenic, self-renewing
ridge  from 9-week-old foetuses. Embryonic Germ (EG) progenitor cells that have the ability to divide for an
cells from each foetus were used to establish a separate indefinite period and can give rise to one or more
culture line. differentiated cell types (Vejjajiva, 2002), which ability is
These discoveries can be considered to be the staring known as developmental plasticity. 
point of what eventually became a plethora of evidence Stem cells are classified into different types and the
that has emerged since then, suggesting that these ES different types exhibit a different degree of plasticity. A
cells are capable of becoming almost any of the fertilized egg (zygote) is able to give rise to all cells of the
specialised cells in the body and therefore have the body and has the highest degree of developmental
potential to generate replacement cells for a broad array of plasticity. It is thus said to be totipotent. Blastomeres are
tissues and organs such as the heart, liver, pancreas and initially totipotent but their level of plasticity decreases
nervous system. Furthermore, other kinds of stem cells quickly. In fact, blastomeres from a five-day human
have been identified and it was found that the variety of embryo (consisting of about 200 cells) are said to be
cells that can be produced from each kind of stem cells pluripotent because they can only give rise to a limited
differs under different laboratory conditions. range  of cell types.  As the embryo continues to develop,
possibilities for stem research seem truly endless and yet
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Table 1: A comparison of the different types of stem cells in terms of their plasticity
Level of plasticity Type of cells Cell types obtainable
Totipotent Zygote All cell types-develops into embryo
Pluripotent a)Embryonic Stem cells (ES cells) All cell types-does not develop into an embryo
Pluripotent b)Umbilical Stem cells Same as ES cells
Pluripotent to multipotent Adult Stem cells
a)Haematopoeitic stem cells Red, white blood cells, immune cells, others?
(refer in this study)
b)Mesenchymal stem cells lipocytes, cartilage, bone, tendon and ligaments,
myocytes, skin cells, neurons
c)Others (methods of collection still not very well-characterized) Neurons, hepatocytes, pneumocytes…
d)Transdifferentiation (occurs under special conditions) Crossing of germ layers
individual cells become multipotent- they are able to give
rise to only a few cell types.  Hence it is now known that
mesenchymal stem cells, which were the first non-
haemotopietic progenitors to be isolated from the bone
marrow and are now extensively characterised, can
differentiate into osteocytes, tenocytes, adiposities and
smooth muscle cells, in addition to their ability to support
haematopoiesis (Koc and Lazarus, 2001). Finally, cells
become specialized. This means that by definition, they
either give rise only to cells of their own kind, or else lose
the ability to reproduce completely (as in a neuron, for
example).
Stem cells are currently classified according to their
origin, which may be from embryo, umbilical cords or adult
tissue. Cord and ES cells are generally said to be
equivalent to pluripotent blastomeres, while adult stem
cells (which are also found in children as well as in adults)
possess a wider range of plasticity ranging from
pluripotent to multipotent (Table 1). Fig. 1: Derivation of hES cells (Thomson et al., 1998)
Embryonic Stem cells (ES cells):  ES cells are derived cells were dissociated and replated on fresh feeder plates
from the Inner Cell Mass (ICM) of the blastocyst and are in order to induce the formation of embryoid bodies
capable of generating all differentiated cells types in the (aggregations of cells into small clumps). The hES cells
body, as represented the three germ layers. However, it is were after maintained for months in the undifferentiated
worth noting that since the association between the ICM state by serially sub-culturing cells from the edge of the
and the trophoblast is disrupted (when ES cells are placed embryoid bodies onto fresh, irradiated mouse embryonic
in culture), the ES cells can’t develop into an embryo. fibroblast feeder layers (Fig. 1).
Hence they are said to be pluripotent as opposed to Thomson’s  team  began with 35 embryos, of which
totipotent. In culture, ES cells are immortal, proliferating 14 reached the blastocyst stage. The ICM was isolated
indefinitely while retaining an embryonic phenotype. from these embryos and used to establish 5 human
Methods of collection of ES cells are continually embryonic cell lines: H7, H9, H1, H13 and H14, the former
being  discovered.  Two  protocols are described here: 2 being female and the latter three being male. The ES cell
One was  used  by   Thomson  (1998), the other by lines were continuously cultured for several months and
Klimanskaya  et  al. (2006) as a method by which hES cells expressed high levels of telomerase activity, characteristic
were derived from single blastomeres without damaging of cells with high reproductive live span and expressed
their embryonic source (Klimanskaya et al., 2006). cell surface markers characteristic of ES cells, including
The  protocols  utilised by Thomson et al. (1998), Stage-Specific  Embryonic  Antigen m (SSEA)-3, SSEA-4,
involved the isolation of stem cells from the ICM of T-Cell Receptor Alpha (TRA)-1-1-60, TRA-1-81 and
human blastocysts, obtained from an IVF clinic. After alkaline phosphatase. 
culturing to the blastocyst stage, the ICMs were removed The 5 original cell lines continue to divide without
and cultured on irradiated mouse embryonic fibroblast differentiating for 6 months and were able to form
feeder  layers. After  about  two  weeks in culture, the hES teratomas in mice when grown into Severe Combined
Irradiated mouse 
Fibroblast cells 
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Immunodeficient (SCID) mice. Histology of the tumours stored for many years in case they may be needed. In case
revealed differentiated cells derived from all three of need, the stem cells are released to the physician
embryonic germ layers including gut epithelium treating the person at precisely the time they are needed.
(endoderm), cartilage, bone, smooth and striated muscle Hence there is no need to search for a donor. Furthermore,
(mesoderm) and neural epithelium, embryonic ganglia and the collection procedure has no effect whatsoever on the
stratified squamous epithelium (ectoderm) a result baby or the mother. 
consistent with pluripotency. Cell line H9 went on to UCS cells have been shown to have an excellent
proliferate for more than two years and is now being used developmental plasticity, even equalling that of ES cells.
by research groups around the world. All cell lines Other advantages include a significantly reduced rate of
continued to maintain a normal karyotype. This Graft-Versus-Host Disease (GVHD) and greater
observation was crucial because if the cells grew well in immunological naivete compared to bone marrow
culture but suffered chromosomal damage (broken (Laughlin et al., 2001); a higher acceptance rate for cord
chromosomes or daughter cells that received and blood for HLA matched siblings (Rocha et al., 2000) as
incorrect number of chromosomes), they would have been well as for HLA mismatched recipients (Long et al., 2003)
useless for medical therapy. and a significantly reduced chance of transplant patients
In a more recent development, Klimanskaya et al. receiving umbilical cord blood transplants from a relative,
(2006) published a series of 10 separate experiments to develop GVHD (Gluckman et al., 1997) although other
demonstrating that hES cells can be derived from single factors may have to be considered (Madrigal et al., 1997).
blastomeres (as opposed to removing the whole ICM). Furthermore, the rapid availability of cord blood for
The results consisted of nineteen ES-cell-like outgrowths transplantation is a particular advantage for those
and two stable hES cell lines. The latter hES cell lines patients requiring urgent transplantation (Barker et al.,
maintained undifferentiated proliferation  for  more  than 2002; Sanz and Sanz, 2002).
8 months and showed normal karyotype and expression The first umbilical cord blood transplant was
of markers of pluripotency, including Oct-4, SSEA-3, performed in 1970 on a 16-year-old boy with acute
SSEA-4, TRA-1-60, TRA-1-81, nanog and alkaline lymphoblastic leukaemia (Ende and Ende, 1972). The boy
phosphatase. It was noted that the cells retained the received cord blood units from 8 different unrelated
potential to form derivatives of all three embryonic germ donors, untested for any HLA compatibility, over 18 days.
layers both in vitro and in teratomas. These lines Only 1 unit engrafted, but the patient remained in
displayed  undifferentiated  proliferation  for  more  than complete remission with maintenance chemotherapy until
8 months  and  appeared  to  be  comparable in all aspects his last follow-up appointment at 9 months. 
to  lines derived with conventional techniques. Hence,  it Since then, umbilical cord blood storage and
follows  that  the  cells  obtained  in  this  experiment  are transplantation is now widely accepted by the medical
comparable  to those obtained by Thomson et al. (1998) and scientific profession as a valid and immensely useful
as regards plasticity. Furthermore, numerous reports procedure. After expansion in culture, cord blood cells are
suggest  that  neither  the survival rate nor the able to express the phenotype of multiple lineages,
subsequent development and chances of implantation including  for example adhesion molecules CD13+, CD29+
differ between intact human embryos at the blastocyst and CD34+. Cord blood may prove to be a new source of
stage and those following blastomere biopsy for cells for cellular therapeutics for stromal, bone and
Preimplantation Genetic Diagnosis (PDG). potentially,  neural  repair  (Goodwin  et al., 2001). More
The ability to create new stem cell lines and therapies than  3,000  patients  with  at  least  45 different
without destroying embryos would address the ethical pathologies have now been treated using cord blood cells
concerns of many and allow the generation of matched (Fasouliotis and  Schenker, 2000; Barker and Wagner,
tissue for children and siblings born from transferred PGD 2002). Diseases which have been cured by UCS cells
embryos. include Fanconi anemia (Croop et al., 2001), Chronic
Umbilical Cord Stem (UCS) cells: The collection of UCS cancer (Paquette et al., 2000) and many others. In 2004,
cells involves the insertion of a needle into the umbilical the first case of autologous cord blood transplantation
cord, in order to allow the blood to drain into a specially was reported,  in  relation  to  the  treatment  of  severe
designed collection bag. Once at the storage lab, the aplastic anaemia secondary to liver transplantation
sample is processed to concentrate the stem cells and the (Fruchtman et al., 2004).
cells are then frozen in liquid nitrogen. At this very low UCS cells, collected from millions of infants, could in
temperature the cells are completely stable and can be time, become an extremely valuable tissue bank that could
Myelogenous Leukemia (Wadhwa  et  al.,  2002), breast
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be used to treat many diseases without prompting immune inability to reliably identify and isolate these rare cells
rejection. Additionally it does not raise ethical problems from the heterogeneous populations in which they
associated with ES cells. typically reside and perhaps more importantly, to grow
Adult stem cells: Adult stem cells (also known as somatic multiple cell division. This latter observation is crucial, as
stem cells, derived from Greek GTµ"J46óH, of the body) large numbers of cells are needed for stem cell
are defined as undifferentiated cells found throughout the replacement therapies. In fact, research today tries to
body that divide to replenish dying cells and regenerate analyse the optimum conditions for culturing of adult
damaged tissues. The term adult stem cells are somewhat stem cells by altering culture microenvironment, although
misleading as they can be found in both children and a lot needs to be done to determine the mechanism(s)
adults. which allows this to happen. Hence, the developmental
Adult Stem cells were first cultured and transplanted potential of adult somatic stem cells are continually being
in lab animals by Alexander Friedenstein, Maureen Owen reassessed and redefined, in this fast-moving science
and their coworkers. Transplantation was performed in (Magli et al., 2000).
either in closed systems (diffusion chambers), or open Two examples of adult stem cells which are well- 
systems (under the renal capsule, or subcutaneously) to characterised today are haematopoietic and mesenchymal 
characterize cells that compose the physical stroma of stem cells:
bonemarrow (Friedenstein  et al., 1966, 1970; Owen, 1988). 
Since there is very little extracellular matrix present in C Haematopoietic stem cells were the first stem cells to 
marrow, gentle mechanical disruption (usually by be used successfully in therapies and have been used
pipetting and passage through syringe needles of for decades to treat leukaemia and other blood
decreasing sizes) can readily dissociate stroma and disorders (Bush et al., 2000).  
haematopoietic cells into a single-cell suspension. These C More recently, their use in treatment of breast cancer 
cells are then plated at low density, resulting in the rapid (Damon et al., 2000) and coronary artery diseases 
adhesion of Bone Marrow Stromal Cells (BMSCs), which (Strauer et al.,  2001) has also been explored. While
can then be easily separated from the nonadherent this and other results are encouraging, it is still not
haematopoietic cells by repeated washing. With clear whether they could be used on a clinical scale to 
appropriate culture conditions, distinct colonies are restore tissues and organs other than blood and the 
formed, each of which is derived from a single precursor immune system. In fact haematopoietic stem cells’ 
cell, the CFU-F. potential to produce cell types other than blood cells
As regards plasticity, tissue-specific adult stem cells has become the subject of intense scientific
can generate a whole spectrum of cell types of other controversy and will perhaps continue to dominate
tissues, even crossing germ layers (Filip et al., 2004), the scientific community for years to come.
under special conditions, which phenomenon is referred
to as stem cell transdifferentiation. It was noted that Mesenchymal cells, also found in the bone marrow,
transdifferentiation can be induced by modifying the can form a variety of cell in the laboratory, including
growth medium when stem cells are cultured in vitro or by lipocytes, cartilage, bone, tendon and ligaments,
transplanting them to an organ of the body different from myocytes, skin cells and even neurons.
the one they were originally isolated from. An advantage of using adult stem cells is that the
A novel use for adult stem cells has been reported patient's own cells could be expanded in culture and then
recently by Voltarelli and his team, who transplanted reintroduced into the patient, meaning that the cells would
haematopoietic stem cells in 15 newly diagnosed Type 1 not be rejected by the immune system. This represents a
diabetes mellitus patients. Of these, 14 became insulin-free significant advantage as immune rejection is a difficult
(for a variable length of time), leading the scientists to problem that can only be circumvented with
infer  that  autologous  non-myeloablative  haematopoietic immunosuppressive drugs.
stem cell transplantation increased $ cell function in all
but one patient. Furthermore, it was found that prolonged CONCLUSION
insulin independence resulted in the majority of patients
(Voltarelli et al., 2007). The promise of stem cells lies in the fact that unlike
Despite their enormous potential, protocols for skin, liver, bone marrow and other tissues in the body,
expanding the numbers of adult stem cells in cell culture some   organs   do   not   retain   the   ability  to regenerate.
have not yet been worked out, primarily because of an Hence, scientists are now learning how to coax stem cells
populations of cells that retain stem cell properties over
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into producing the latter kind of cells in the hope of being Filip, S., D. English and J. Mokrý, 2004. Issues in stem cell
able to treat diseases which were hitherto only managable
and not curable. Such disease include neurodegenerative
diseases like Parkinson’s Disease (PD) and Alzheimer’s
Disease (AD), tumours such as luekemia and brain
tumours, anaemias, autoimmune disease such as Multiple
Sclerosis  and  Systemic  Lupus   Erythomatosus  (SLE)
and cardiovascular diseases to mention just a few
examples.
It is important to remember however, that this platonic
scenario is only possible at the cost of doing away with
some of the values which form the very basis of our
society. Hence it is up to us, today’s students and
tomorrow’s researchers, to contribute and shape our
future by striking a balance between old and new,
permanence and change, tradition and innovation. We
can only achieve this by understanding the scientific,
legal, social, ethical and economic aspect which influence
this crucial area of research.
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